Your browser doesn't support javascript.
loading
Integrating molecular, histopathological, neuroimaging and clinical neuroscience data with NeuroPM-box.
Iturria-Medina, Yasser; Carbonell, Félix; Assadi, Atousa; Adewale, Quadri; Khan, Ahmed F; Baumeister, Tobias R; Sanchez-Rodriguez, Lazaro.
Afiliação
  • Iturria-Medina Y; Neurology and Neurosurgery Department, Montreal Neurological Institute, Montreal, Canada. yasser.iturriamedina@mcgill.ca.
  • Carbonell F; McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Canada. yasser.iturriamedina@mcgill.ca.
  • Assadi A; Ludmer Centre for Neuroinformatics & Mental Health, Montreal, Canada. yasser.iturriamedina@mcgill.ca.
  • Adewale Q; Biospective Inc., Montreal, Canada.
  • Khan AF; Neurology and Neurosurgery Department, Montreal Neurological Institute, Montreal, Canada.
  • Baumeister TR; McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal, Canada.
  • Sanchez-Rodriguez L; Ludmer Centre for Neuroinformatics & Mental Health, Montreal, Canada.
Commun Biol ; 4(1): 614, 2021 05 21.
Article em En | MEDLINE | ID: mdl-34021244
ABSTRACT
Understanding and treating heterogeneous brain disorders requires specialized techniques spanning genetics, proteomics, and neuroimaging. Designed to meet this need, NeuroPM-box is a user-friendly, open-access, multi-tool cross-platform software capable of characterizing multiscale and multifactorial neuropathological mechanisms. Using advanced analytical modeling for molecular, histopathological, brain-imaging and/or clinical evaluations, this framework has multiple applications, validated here with synthetic (N > 2900), in-vivo (N = 911) and post-mortem (N = 736) neurodegenerative data, and including the ability to characterize (i) the series of sequential states (genetic, histopathological, imaging or clinical alterations) covering decades of disease progression, (ii) concurrent intra-brain spreading of pathological factors (e.g., amyloid, tau and alpha-synuclein proteins), (iii) synergistic interactions between multiple biological factors (e.g., toxic tau effects on brain atrophy), and (iv) biologically-defined patient stratification based on disease heterogeneity and/or therapeutic needs. This freely available toolbox ( neuropm-lab.com/neuropm-box.html ) could contribute significantly to a better understanding of complex brain processes and accelerating the implementation of Precision Medicine in Neurology.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Software / Encefalopatias / Biologia Computacional / Neuroimagem / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Software / Encefalopatias / Biologia Computacional / Neuroimagem / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2021 Tipo de documento: Article